Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 31 min ago
Peer-reviewedCC BY 4.0PLOS Global Public Health

Impact of cervical cancer–related stigma on screening uptake in Dakar and Kedougou, Senegal: A context-specific stigma index

9 more authors
14 affiliations
  1. 1Institute of Health and Development, Cheikh Anta Diop University, Dakar, Senegal
  2. 2Division of Epidemiology & Biostatistics, School of Public Health, University of Illinois Chicago, Chicago, Illinois, United States of America
  3. 3Obstetrics and Gynecology, Aristide Le Dantec Teaching Hospitals, Cheikh Anta Diop University, Dakar, Senegal
  4. 4Center for Training in Women’s Health, Cheikh Anta Diop University, Dakar, Senegal
  5. 5Office of Cancer Prevention and Control, Division of Non-Communicable Diseases, Ministry of Health and Social Action, Dakar, Senegal
  6. 6Office of Planning, Monitoring, Evaluation, and Research, Division of Maternal and Child Health, Ministry of Health and Social Action, Dakar, Senegal
  7. 7School of Public Health, Epidemiology Division, University of Illinois Chicago, Chicago, Illinois, United States of America
  8. 8Department of Human Development Nursing Science, College of Nursing, University of Illinois Chicago, Chicago, Illinois, United States of America
  9. 9College of Applied Health Sciences, University of Illinois Chicago, Chicago, Illinois, United States of America
  10. 10Department of Biomedical & Health Information Sciences, College of Applied Health Sciences, University of Illinois Chicago, Chicago, Illinois, United States of America
  11. 11College of Medicine, University of Illinois Chicago, Chicago, Illinois, United States of America
  12. 12Department of Family and Community Medicine, University of Illinois Chicago, Chicago, Illinois, United States of America
  13. 13Center for Global Health at the College of Medicine, University of Illinois Chicago, Chicago, Illinois, United States of America
  14. 14Cancer Center, University of Illinois Chicago, Chicago, Illinois, United States of America

Abstract

Cervical cancer is a major public health problem, but it can be prevented through screening and treatment of precancerous lesions. The aim of this study was to assess the association between cervical cancer-related stigma and prior cervical cancer screening uptake among women in the Dakar and Kédougou regions of Senegal. A quantitative descriptive and analytical cross-sectional study was carried out in the Dakar and Kédougou regions. The study population consisted of women aged 25–69. Sampling was based on a two-stage cluster sampling methodology. Past participation in screening was self-reported, and an index of stigma was developed to quantify the level of cervical cancer related stigma in the study population. The items used to develop this index covered several domains that have been shown to be powerful predictors of stigma. Data were analyzed with R 4.5.0 software. Logistic regression was performed (5% alpha). A total of 287 women had data on their screening status, with only 15.7% reporting having undergone one or more screenings in the past. The mean age of participants was 36.23, and the majority (68.6%) were married and living in monogamous households. After adjustment for age, marital status and education level, higher stigma scores were associated with lower odds of screening (OR=0.58, 95% CI 0.38-0.83, p = 0.006). Cervical cancer stigma was significantly associated with lower odds of screening uptake. A better understanding of this barrier will enable us to better adapt strategies to combat this disease. Setting up a navigation program for this screening could help improve access to this service by removing the stigma barrier and any other major obstacle to screening. Our stigma index provides a comprehensive assessment of stigma and represents a novel tool that can be adapted for future research, including the evaluation of stigma reduction following implementation of our patient navigation intervention.

Related

  1. Healthcare access, cervical cancer screening, and urogenital health among masculine-presenting people assigned female at birth in Thailand: The HAFFU Project
    Raksina Winaitammakul, Marc Piñol Rovira, Apisith Saraluck
    BMC Public HealthPeer-reviewedCC BY-NC-ND 4.0Epidemiology & public healthCrossref
  2. Perceived barriers and facilitators influencing cervical and breast cancer screening among healthcare professionals in the Cape Coast Metropolis, Ghana: An explanatory mixed-methods study
    Stephen Mensah Arhin, Patience Ami Kponyoh, Christopher Alatarige
    BMC Public HealthPeer-reviewedCC BY 4.0Epidemiology & public healthCrossref
  3. Impact of HPV vaccination on high-risk HPV prevalence in 25-29-year-old women attending cervical screening in England 2016-2025
    L. Slater, K. Panwar, M. Checchi +6
    medRxivPreprintAll rights reservedFull textObstetrics, gynaecology & paediatricsmedRxiv
  4. Facilitating HPV DNA test-based screening for cervical cancer in public health settings of India: learnings from the Amethi project
    Nuzhat Husain, Parag Bhamare, Sabuhi Qureshi +6
    BMC Public HealthPeer-reviewedCC BY-NC-ND 4.0Epidemiology & public healthCrossref
  5. Universal cervical length screening and vaginal progesterone: Distinguishing strategy effectiveness from treatment efficacy
    Mira Zethelius, Lina Bergman, Ann‐Catrin Ekelund +9
    Acta Obstetricia et Gynecologica ScandinavicaPeer-reviewedCC BYFull textEpidemiology & public healthDOAJ
BibTeX
@article{seck2026impact,
  title = {{Impact of cervical cancer–related stigma on screening uptake in Dakar and Kedougou, Senegal: A context-specific stigma index}},
  author = {Fatou Bintou Seck and Saria Awadalla and Fatoumata Binetou Diongue and Ibrahima Ndiaye and Omar Gassama and Ndeye Mbombe Dieng and Adja Maguette Diaw and Hilaire Sarr and Victoria Winslow and Ndèye Marème Sougou and Sarah Abboud and Assane Sall and Alexis Claire Klima and Aida Fall and Aida Barro and Blessings Chisunkha and Ahmadou Babana El Alaoui and Aliath Salami and Jon Andrew Dykens and Caryn Elizabeth Peterson and Adama Faye},
  journal = {PLOS Global Public Health},
  year = {2026},
  month = oct,
  doi = {10.1371/journal.pgph.0006187},
  url = {https://journals.plos.org/globalpublichealth/article?id=10.1371/journal.pgph.0006187},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Impact of cervical cancer–related stigma on screening uptake in Dakar and Kedougou, Senegal: A context-specific stigma index
AU  - Fatou Bintou Seck
AU  - Saria Awadalla
AU  - Fatoumata Binetou Diongue
AU  - Ibrahima Ndiaye
AU  - Omar Gassama
AU  - Ndeye Mbombe Dieng
AU  - Adja Maguette Diaw
AU  - Hilaire Sarr
AU  - Victoria Winslow
AU  - Ndèye Marème Sougou
AU  - Sarah Abboud
AU  - Assane Sall
AU  - Alexis Claire Klima
AU  - Aida Fall
AU  - Aida Barro
AU  - Blessings Chisunkha
AU  - Ahmadou Babana El Alaoui
AU  - Aliath Salami
AU  - Jon Andrew Dykens
AU  - Caryn Elizabeth Peterson
AU  - Adama Faye
PY  - 2026
DA  - 2026/10/08
JO  - PLOS Global Public Health
DO  - 10.1371/journal.pgph.0006187
UR  - https://journals.plos.org/globalpublichealth/article?id=10.1371/journal.pgph.0006187
AB  - Cervical cancer is a major public health problem, but it can be prevented through screening and treatment of precancerous lesions. The aim of this study was to assess the association between cervical cancer-related stigma and prior cervical cancer screening uptake among women in the Dakar and Kédougou regions of Senegal. A quantitative descriptive and analytical cross-sectional study was carried out in the Dakar and Kédougou regions. The study population consisted of women aged 25–69. Sampling was based on a two-stage cluster sampling methodology. Past participation in screening was self-reported, and an index of stigma was developed to quantify the level of cervical cancer related stigma in the study population. The items used to develop this index covered several domains that have been shown to be powerful predictors of stigma. Data were analyzed with R 4.5.0 software. Logistic regression was performed (5% alpha). A total of 287 women had data on their screening status, with only 15.7% reporting having undergone one or more screenings in the past. The mean age of participants was 36.23, and the majority (68.6%) were married and living in monogamous households. After adjustment for age, marital status and education level, higher stigma scores were associated with lower odds of screening (OR=0.58, 95% CI 0.38-0.83, p = 0.006). Cervical cancer stigma was significantly associated with lower odds of screening uptake. A better understanding of this barrier will enable us to better adapt strategies to combat this disease. Setting up a navigation program for this screening could help improve access to this service by removing the stigma barrier and any other major obstacle to screening. Our stigma index provides a comprehensive assessment of stigma and represents a novel tool that can be adapted for future research, including the evaluation of stigma reduction following implementation of our patient navigation intervention.
SN  - 2767-3375
ER  -